| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4002583 | American Journal of Ophthalmology | 2012 | 9 Pages |
Abstract
Monthly injections of ranibizumab for 3 months to treat PCV improved the VA, and a reinjection schedule based on need maintained the improved VA. The polypoidal lesions tended to improve over 1 year, whereas abnormal choroidal vessels remained in all eyes. Further long-term follow-up is needed to determine the efficacy of ranibizumab therapy for PCV.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Taiichi Hikichi, Makoto Higuchi, Takuro Matsushita, Shoko Kosaka, Reiko Matsushita, Kimitaka Takami, Hideo Ohtsuka, Hiroko Ariga,